SE7604162L - Mellanprodukter for framstellning av morfinanderivat med analgetisk och/eller narkotikumantagonistverkan - Google Patents

Mellanprodukter for framstellning av morfinanderivat med analgetisk och/eller narkotikumantagonistverkan

Info

Publication number
SE7604162L
SE7604162L SE7604162A SE7604162A SE7604162L SE 7604162 L SE7604162 L SE 7604162L SE 7604162 A SE7604162 A SE 7604162A SE 7604162 A SE7604162 A SE 7604162A SE 7604162 L SE7604162 L SE 7604162L
Authority
SE
Sweden
Prior art keywords
analgetic
preparation
intermediate products
antagonist effect
morphinan derivatives
Prior art date
Application number
SE7604162A
Other languages
English (en)
Other versions
SE411042B (sv
Inventor
I Monkovic
T T Conway
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE7604162L publication Critical patent/SE7604162L/sv
Publication of SE411042B publication Critical patent/SE411042B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/28—Morphinans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
SE7604162A 1972-05-10 1976-04-08 Mellanprodukter for framstellning av morinanderivat med analgetisk och/eller narkotikumantagonistverkan SE411042B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25187972A 1972-05-10 1972-05-10

Publications (2)

Publication Number Publication Date
SE7604162L true SE7604162L (sv) 1976-04-08
SE411042B SE411042B (sv) 1979-11-26

Family

ID=22953785

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7306479A SE403106B (sv) 1972-05-10 1973-05-08 Forfarande vid framstellning av 14-hydroximorfinanderivat
SE7604162A SE411042B (sv) 1972-05-10 1976-04-08 Mellanprodukter for framstellning av morinanderivat med analgetisk och/eller narkotikumantagonistverkan

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7306479A SE403106B (sv) 1972-05-10 1973-05-08 Forfarande vid framstellning av 14-hydroximorfinanderivat

Country Status (13)

Country Link
US (1) US3775414A (sv)
JP (1) JPS535672B2 (sv)
CA (1) CA989827A (sv)
CH (1) CH590238A5 (sv)
CS (3) CS178446B2 (sv)
DD (1) DD106841A5 (sv)
DK (1) DK138492B (sv)
HU (2) HU169023B (sv)
IL (1) IL42219A (sv)
NL (1) NL155256B (sv)
OA (1) OA04406A (sv)
SE (2) SE403106B (sv)
YU (1) YU36505B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910920A (en) * 1973-11-07 1975-10-07 Bristol Myers Co 3,14,17-Substituted-6,7-tetramethylenemorphinans
US3980641A (en) * 1975-07-31 1976-09-14 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinans
US4017497A (en) * 1975-11-18 1977-04-12 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
JPS52136176A (en) * 1976-03-23 1977-11-14 Bristol Myers Co Method of improving 144hydroxymorphinan derivatives
US4139534A (en) * 1977-02-17 1979-02-13 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
US4052389A (en) * 1976-03-23 1977-10-04 Bristol-Myers Company Derivatives of 9,10-dihydroxy-1-(p-alkoxybenzyl)-perhydroisoquinoline oxazine-3-one
US4115389A (en) * 1977-05-02 1978-09-19 Bristol-Myers Company Process of N-demethylating (-)-1-(p-methoxybenzyl)-2-methyl-1,2,3,4,5,6,7,8-octahydroisoquinoline
NO793297L (no) * 1978-10-19 1980-04-22 Mallinckrodt Inc Fremgangsmaate til fremstilling av oksymorfon
US4272540A (en) * 1979-04-24 1981-06-09 Sisa, Incorporated 14-Methoxymorphinan-6-one compounds and therapeutic methods of treating pain and drug dependence with them
NO802139L (no) * 1979-08-09 1981-02-10 Mallinckrodt Inc Utgangsforbindelser for fremstilling av morfinderivater, samt fremgangsmaate til fremstilling av utgangsforbindelsene
US5109136A (en) * 1990-08-09 1992-04-28 Warner-Lambert Company Tetracyclic amines useful as cerebrovascular agents
US10307381B2 (en) 2014-10-14 2019-06-04 Hisamitsu Pharmaceutical Co., Inc. Patch
MX2018011877A (es) * 2016-03-29 2019-03-06 Hikal Ltd Proceso mejorado para la preparacion de tartrato de butorfanol.
KR102279552B1 (ko) 2016-12-28 2021-07-19 히사미쓰 세이야꾸 가부시키가이샤 부토르파놀 함유 첩부제
WO2018198925A1 (ja) 2017-04-25 2018-11-01 久光製薬株式会社 貼付剤
CN110545816B (zh) 2017-04-25 2023-04-11 久光制药株式会社 贴附剂
CN112592342B (zh) * 2021-01-15 2022-02-22 福安药业集团重庆礼邦药物开发有限公司 一种布托啡诺脱环丁基杂质化合物的制备方法

Also Published As

Publication number Publication date
NL155256B (nl) 1977-12-15
HU168597B (sv) 1976-06-28
CA989827A (en) 1976-05-25
DK138492C (sv) 1979-02-19
SE411042B (sv) 1979-11-26
IL42219A (en) 1977-06-30
YU119773A (en) 1982-02-25
CS178447B2 (sv) 1977-09-15
SE403106B (sv) 1978-07-31
NL7306344A (sv) 1973-11-13
DD106841A5 (sv) 1974-07-05
OA04406A (fr) 1980-02-29
CH590238A5 (sv) 1977-07-29
HU169023B (sv) 1976-09-28
DK138492B (da) 1978-09-18
YU36505B (en) 1984-02-29
JPS535672B2 (sv) 1978-03-01
US3775414A (en) 1973-11-27
IL42219A0 (en) 1973-07-30
CS178425B2 (sv) 1977-09-15
CS178446B2 (sv) 1977-09-15
JPS4961169A (sv) 1974-06-13

Similar Documents

Publication Publication Date Title
SE7604162L (sv) Mellanprodukter for framstellning av morfinanderivat med analgetisk och/eller narkotikumantagonistverkan
NO780402L (no) Fremgangsmaate ved fremstilling av benzodiazepinderivater
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
BE764659A (fr) Nouveaux derives de l'indole, leur preparation et medicaments contenantces derives
BE764660A (fr) Nouveaux derives de l'indole, leur preparation et medicaments contenantces derives
SE409855B (sv) Forfarande for framstellning av hydroxisubstituerade bifenylylpropionsyror och derivat derav
SE397523B (sv) Forfarande att framstella n-fenylpyrrolderivat med antiinflammatorisk och analgetisk verkan
SE407935B (sv) Forfarande for framstellning av nya 8-aryl-9-oxo-alkansyror och vissa hogre homologer derav med anvendning som lekemedel
FI55511B (fi) Foerfarande foer framstaellning av farmaceutiskt verksamt n-(heteroarylmetyl)-normorfinon-derivat och dess syraadditionssalter
SE385471B (sv) Forfarande for framstellning av bensobicykloalkanaminer med analgetisk eller anti-inflammatorisk lekemedelsverkan
SE394434B (sv) Forfarande for framstellning av vissa angivna s-triazinderivat och dess farmaceutiskt godtagbara salter
SE399557B (sv) Forfarande for framstellning av tiantren-, tioxanten- och fenoxatiinderivat
SE393801B (sv) Forfarande for framstellning av tiokarbaminsyraderivat med antifungistatisk lekemedelsverken
SE382970B (sv) Forfarande for framstellning av fosgen med utgaende fran klor och koloxid
SE396595B (sv) Forfarande for framstellning av difenylamin och derivat derav
SE401829B (sv) Forfarande for framstellning av 5-fenyl-6,7-bensomorfanderivat och salter derav
SE398230B (sv) Forfarande for framstellning av 1-amino-3-/(pyrrody-1)-fenoxi/-2-propanol och derivat derav med terapeutisk verkan
SE400287B (sv) Forfarande for framstellning av fluorsubstituerade tiaxantenderivat
SE388195B (sv) Forfarande for framstellning av 2,5-dihydroxibensensulfonsyraderivat med hemostatisk hypokolesterolemisk, hypotriglyceridemisk och hypolipemisk verkan
BE773205A (fr) Nouveaux derives de l'indole, leur preparation et medicaments contenantces derives
SE7806349L (sv) Mellanprodukter avsedda for framstellning av trien-steroidderivat
ZA733638B (en) New heterocyclic derivatives preparation process and pharmaceutical compositions
SE7713835L (sv) Forfarande for framstellning av 1alfa-hydroxicholekalciferol och mellanprodukter for anvendning i forfarandet
SE380526B (sv) Forfarande for framstellning av derivat av tienobensopyran och tiopyranobensopyran
SE399254B (sv) Forfarande for framstellning av kinazolinonderivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7604162-3

Effective date: 19930610

Format of ref document f/p: F